未登录 分享 收藏
分享 收藏
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials Price, Sarah N.; Lee, Ju-Whei; Gareen, Ilana F.; Kircher, Sheetal M.; Kumar, Shaji K.; Mayer, Ingrid A.; Saba, Nabil F.; Fenske, Timothy S.; Atkins, Michael B.; Hodi, F. Stephen; Kyriakopoulos, Christos E.; Tempany-Afdhal, Clare M.; Shanafelt, Tait D.; Park, Elyse R.; Wagner, Lynne I. 分享 收藏
CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2-early breast cancer Hamilton, Erika P.; Loibl, Sibylle; Bachelot, Thomas; Gnant, Michael; Niikura, Naoki; Park, Yeon Hee; Tolaney, Sara M.; Pistilli, Barbara; Rastogi, Priya; Saini, Kamal S.; Gioni, Ioanna; Johnston, Simon; Nunes, Raquel; Quintana, Angela; Stuart, Mary; Syta, Emilia; Walding, Andrew; Klinowska, Teresa; Mayer, Ingrid A. 分享 收藏
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105) Mezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A.; Arteaga, Carlos L.; Yang, Ximing J.; Wagner, Lynne I.; Cella, David; Meropol, Neal J.; Alpaugh, R. Katherine; Saphner, Thomas J.; Swaney, Robert E.; Hoelzer, Karen L.; Gradishar, William J.; Abramson, Vandana G.; Sundaram, P. Kothai; Jilani, Shamim Z.; Perez, Edith A.; Lin, Nancy U.; Jahanzeb, Mohammad; Wolff, Antonio C.; Sledge, George W.; Reid, Sonya A. 分享 收藏
A Phase 3, randomized, open-label study of upfront camizestrant vs standard endocrine therapy as adjuvant treatment for ER-positive/HER2negative early breast cancer with intermediate-high or high risk of recurrence (CAMBRIA-2) Loibl, Sibylle; Park, Yeon; Tolaney, Sara; Gioni, Ioanna; Johnston, Simon; Klinowska, Teresa; Mayer, Ingrid A.; Nunes, Raquel; Pistilli, Barbara; Stuart, Mary; Quintana, Angela; Walding, Andrew; Gnant, Michael 分享 收藏
A phase 3 randomized open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy in patients with ER+/HER2-early breast cancer and an intermediate or high risk of recurrence (CAMBRIA 1) Hamilton, Erika; Loibl, Sibylle; Niikura, Naoki; Rastogi, Priya; Saini, Kamal S.; Gioni, Ioanna; Klinowska, Teresa; Mayer, Ingrid A.; Stuart, Mary; Syta, Emilia; Walding, Andrew; Bachelot, Thomas 分享 收藏
分享 收藏
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131 Smith, Karen L.; Zhao, Fengmin; Mayer, Ingrid A.; Tevaarwerk, Amye J.; Garcia, Sofia F.; Arteaga, Carlos L.; Symmans, William F.; Park, Ben H.; Burnette, Brian L.; Makower, Della F.; Block, Margaret; Morley, Kimberly A.; Jani, Chirag R.; Mescher, Craig; Dewani, Shabana J.; Brown-Glaberman, Ursa; Flaum, Lisa E.; Mayer, Erica L.; Sikov, William M.; Rodler, Eve T.; Demichele, Angela M.; Sparano, Joseph A.; Wolff, Antonio C.; Miller, Kathy D.; Wagner, Lynne I. 分享 收藏
The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG-ACRIN Cancer Research Group (EA) trials Walter, Angela Wangari; Lee, Ju-Whei; Streck, Joanna M.; Gareen, Ilana F.; Herman, Benjamin A.; Kircher, Sheetal M.; Carlos, Ruth C.; Kumar, Shaji K.; Mayer, Ingrid A.; Saba, Nabil F.; Fenske, Timothy S.; Neal, Joel W.; Atkins, Michael B.; Hodi, Frank S.; Kyriakopoulos, Christos E.; Tempany-Afdhal, Clare M.; Shanafelt, Tait D.; Wagner, Lynne I.; Land, Stephanie R.; Ostroff, Jamie S.; Park, Elyse R. 分享 收藏
A phase III randomised open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy (ET) in patients with ER+/HER2-early breast cancer (BC) and an intermediate or high risk of recurrence (CAMBRIA-1) Hamilton, E.; Loibl, S.; Niikura, N.; Rastogi, P.; Saini, K. S.; Gioni, I.; Klinowska, T.; Mayer, I.; Stuart, M.; Syta, E.; Walding, A.; Bachelot, T. 分享 收藏
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer Hermida-Prado, Francisco; Xie, Yingtian; Sherman, Shira; Nagy, Zsuzsanna; Russo, Douglas; Akhshi, Tara; Chu, Zhengtao; Feit, Avery; Campisi, Marco; Chen, Minyue; Nardone, Agostina; Guarducci, Cristina; Lim, Klothilda; Font-Tello, Alba; Lee, Irene; Garcia-Pedrero, Juana; Canadas, Israel; Agudo, Judith; Huang, Ying; Sella, Tal; Jin, Qingchun; Tayob, Nabihah; Mittendorf, Elizabeth A.; Tolaney, Sara M.; Qiu, Xintao; Long, Henry; Symmans, William F.; Lin, Jia-Ren; Santagata, Sandro; Bedrosian, Isabelle; Yardley, Denise A.; Mayer, Ingrid A.; Richardson, Edward T.; Oliveira, Giacomo; Wu, Catherine J.; Schuster, Eugene F.; Dowsett, Mitch; Welm, Alana L.; Barbie, David; Metzger, Otto; Jeselsohn, Rinath 分享 收藏
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials Streck, Joanna M.; Lee, Ju-Whei; Walter, Angela Wangari; Rosen, Rachel L.; Gareen, Ilana F.; Kircher, Sheetal Mehta; Herman, Benjamin A.; Carlos, Ruth C.; Kumar, Shaji; Mayer, Ingrid A.; Saba, Nabil F.; Fenske, Timothy S.; Neal, Joel W.; Atkins, Michael B.; Hodi, F. Stephen; Kyriakopoulos, Christos E.; Tempany, Clare; Shanafelt, Tait D.; Wagner, Lynne I.; Land, Stephanie R.; Park, Elyse R.; Ostroff, Jamie S. 分享 收藏
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2-) advanced/metastatic breast cancer Bardia, Aditya; Mayer, Ingrid; Winer, Eric; Linden, Hannah M.; Ma, Cynthia X.; Parker, Barbara A.; Bellet, Meritxell; Arteaga, Carlos L.; Cheeti, Sravanthi; Gates, Mary; Chang, Ching-Wei; Fredrickson, Jill; Spoerke, Jill M.; Moore, Heather M.; Giltnane, Jennifer; Friedman, Lori S.; Maneval, Edna Chow; Chan, Iris; Jhaveri, Komal 分享 收藏
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer The MA.32 Randomized Clinical Trial Goodwin, Pamela J.; Chen, Bingshu E.; Gelmon, Karen A.; Whelan, Timothy J.; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A.; Hershman, Dawn L.; Mayer, Ingrid A.; Hobday, Timothy J.; Bliss, Judith M.; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D.; Mackey, John R.; Abramson, Vandana G.; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M.; Rea, Daniel W.; Stos, Paul M.; Shepherd, Lois E.; Stambolic, Vuk; Parulekar, Wendy R. 分享 收藏
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer sacituzumab govitecan治疗转移性三阴性乳腺癌的3期随机上升研究中没有和最初诊断为三阴性乳腺癌的患者的分析 O'Shaughnessy, Joyce; Brufsky, Adam; Rugo, Hope S.; Tolaney, Sara M.; Punie, Kevin; Sardesai, Sagar; Hamilton, Erika; Loirat, Delphine; Traina, Tiffany; Leon-Ferre, Roberto; Hurvitz, Sara A.; Kalinsky, Kevin; Bardia, Aditya; Henry, Stephanie; Mayer, Ingrid; Zhu, Yanni; Phan, See; Cortes, Javier 分享 收藏
Upregulation of immune response biomarkers by ribociclib plus endocrine therapy (ET) in paired tumor samples from phase I studies Juric, Dejan; Ma, Chong; Tiedt, Ralph; Yap, Yoon-Sim; Chiu, Joanne; Munster, Pamela; Ismail-Khan, Roohi; Garcia-Estevez, Laura; Mayer, Ingrid A.; Becerra, Carlos; Solovieff, Nadia; Lteif, Agnes; Su, Faye; Lu, Yen-Shen 分享 收藏
CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438) Goodwin, Pamela J.; Chen, Bingshu E.; Gelmon, Karen A.; Whelan, Timothy J.; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A.; Hershman, Dawn L.; Mayer, Ingrid A.; Hobday, Timothy J.; Bliss, Judith M.; Rastogi, Priya; Rabaglio-Poretti, Manuela; Mukherjee, Som D.; Mackey, Robert R.; Abramson, Vandana G.; Oja, Conrad; Wesolowski, Robert; Thompson, Alastair M.; Rea, Daniel W.; Stos, Paul M.; Shepherd, Lois E.; Stambolic, Vuk; Parulekar, Wendy R. 分享 收藏
Balixafortide (a CXCR4 antagonist) plus eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer: An international, randomized, phase 3 trial (FORTRESS) Kaufman, Peter; Martin, Miguel; Mayer, Ingrid; Vahdat, Linda; Pernas, Sonia; Schmid, Peter; McArthur, Heather; Dent, Rebecca; Rugo, Hope S.; Barrios, Carlos; Bobirca, Alexandra; Ringeisen, Francois; Schmitter, Daniela; Cortes, Javier 分享 收藏
Mammaprint and Blueprint identify genomic differences in HR+HER2-breast cancers from young Black and White women Reid, Sonya; Pal, Tuya; Mayer, Ingrid A.; Shu, Xiao-Ou; Tezak, Ann L.; Hoskins, Kent; Sharma, Dipali; Robinson, Patricia; Wei, Jennifer; Ruby, Jake; Wang, Shiyu; Haan, Josien; Menicucci, Andrea; Audeh, William 分享 收藏
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
